The Onchocerciasis Vaccine for Africa--TOVA--Initiative

Affiliations

¹ Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
² Institute of Infection and Global Health, University of Liverpool, Liverpool, England.
³ Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, United States of America.
⁴ Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
⁵ Division of Pathway Medicine, School for Biomedical Studies, University of Edinburgh, Edinburgh, Scotland.
⁶ Laboratory of Molecular Parasitology, Lindsley F Kimball Research Institute, New York Blood Center, New York, New York, United States of America.

Editorial

Peter J Hotez et al. PLoS Negl Trop Dis. 2015.

. 2015 Jan 29;9(1):e0003422.

doi: 10.1371/journal.pntd.0003422. eCollection 2015 Jan.

¹ Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
² Institute of Infection and Global Health, University of Liverpool, Liverpool, England.
³ Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, United States of America.
⁴ Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
⁵ Division of Pathway Medicine, School for Biomedical Studies, University of Edinburgh, Edinburgh, Scotland.
⁶ Laboratory of Molecular Parasitology, Lindsley F Kimball Research Institute, New York Blood Center, New York, New York, United States of America.

No abstract available

Conflict of interest statement

The authors have declared that no competing interests exist.

1. World Bank (2014) World Bank Live, River Blindness: 40th Anniversary Summit. http://live.worldbank.org/river-blindness. Accessed 21 Jun 2014.
1. World Health Organization (2014) Media Centre, Onchocerciasis. http://www.who.int/mediacentre/factsheets/fs374/en/. Accessed 21 June 2014.
1. Coffeng LE, Stolk WA, Zoure HG, Veerman JL, Agblewonu KB, et al. (2013) African Programme For Onchocerciasis Control 1995–2015: model-estimated health impact and cost. PLoS Negl Trop Dis 7: e2032 10.1371/journal.pntd.0002032 - DOI - PMC - PubMed
1. Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, et al. (2012) Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis 6: e1825 10.1371/journal.pntd.0001825 - DOI - PMC - PubMed
1. World Health Organization (2012) World Health Organization’s 2020 Roadmap on NTDs. http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf. Accessed June 21, 2014.